Cyclopiazonic acid inhibits mutagenic action of aflatoxin B(1). 2002

Mariëlla E M Kuilman-Wahls, and Mònica Sabater Vilar, and Lilian de Nijs-Tjon, and Roel F M Maas, and Johanna Fink-Gremmels
Department of Veterinary Pharmacology, Pharmacy and Toxicology, Faculty of Veterinary Medicine, Utrecht University, PO Box 80152, 3508 TD Utrecht, The Netherlands.

Cyclopiazonic acid and aflatoxin B(1) are mycotoxins which can both be produced by the same moulds. Men can be exposed to these mycotoxins directly via ingestion of plant-derived food, as well as, indirectly via consumption of animal products. Although it is well known that aflatoxin B(1) is mutagenic, contradictory results exist on the mutagenicity of cyclopiazonic acid. Using the Ames test cyclopiazonic acid was not found to be mutagenic either with or without metabolic activation by S9-mix of Arochlor treated rats. However, the mutagenicity of aflatoxin B(1) was inhibited in the presence of cyclopiazonic acid. Since cyclopiazonic acid inhibited the formation of certain metabolites of caffeine and testosterone, it was concluded that the reduction of the mutagenicity of aflatoxin B(1) in the presence of cyclopiazonic acid results from the inhibition of the bioactivation of aflatoxin B(1) by certain cytochrome P450 enzymes.

UI MeSH Term Description Entries

Related Publications

Mariëlla E M Kuilman-Wahls, and Mònica Sabater Vilar, and Lilian de Nijs-Tjon, and Roel F M Maas, and Johanna Fink-Gremmels
January 1987, Molecular toxicology,
Mariëlla E M Kuilman-Wahls, and Mònica Sabater Vilar, and Lilian de Nijs-Tjon, and Roel F M Maas, and Johanna Fink-Gremmels
January 1971, Molecular & general genetics : MGG,
Mariëlla E M Kuilman-Wahls, and Mònica Sabater Vilar, and Lilian de Nijs-Tjon, and Roel F M Maas, and Johanna Fink-Gremmels
July 1992, Poultry science,
Mariëlla E M Kuilman-Wahls, and Mònica Sabater Vilar, and Lilian de Nijs-Tjon, and Roel F M Maas, and Johanna Fink-Gremmels
June 2014, Journal of food protection,
Mariëlla E M Kuilman-Wahls, and Mònica Sabater Vilar, and Lilian de Nijs-Tjon, and Roel F M Maas, and Johanna Fink-Gremmels
April 2005, Mycopathologia,
Mariëlla E M Kuilman-Wahls, and Mònica Sabater Vilar, and Lilian de Nijs-Tjon, and Roel F M Maas, and Johanna Fink-Gremmels
July 1973, Biochemical pharmacology,
Mariëlla E M Kuilman-Wahls, and Mònica Sabater Vilar, and Lilian de Nijs-Tjon, and Roel F M Maas, and Johanna Fink-Gremmels
September 1994, Mycotoxin research,
Mariëlla E M Kuilman-Wahls, and Mònica Sabater Vilar, and Lilian de Nijs-Tjon, and Roel F M Maas, and Johanna Fink-Gremmels
April 2014, Food microbiology,
Mariëlla E M Kuilman-Wahls, and Mònica Sabater Vilar, and Lilian de Nijs-Tjon, and Roel F M Maas, and Johanna Fink-Gremmels
November 1996, Applied and environmental microbiology,
Mariëlla E M Kuilman-Wahls, and Mònica Sabater Vilar, and Lilian de Nijs-Tjon, and Roel F M Maas, and Johanna Fink-Gremmels
November 2001, Food additives and contaminants,
Copied contents to your clipboard!